ArticleFrontiers in oncology2022

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types.

Ankang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.